Avid Bioservices Inc (NAS:CDMO)

$ 12.28 -0.07 (-0.57%) Market Cap: 785.38 Mil Enterprise Value: 957.96 Mil PE Ratio: 0 PB Ratio: 13.36 GF Score: 78/100

Q1 2025 Avid Bioservices Inc Earnings Call Transcript
Sep 09, 2024

$8.95 (+1.36%)

Earnings
Q4 2024 Avid Bioservices Inc Earnings Call Transcript
Jul 02, 2024

$6.7 (-5.90%)

Earnings
Q3 2024 Avid Bioservices Inc Earnings Call Transcript
Apr 29, 2024

$7.56 (+2.86%)

Earnings
Q2 2024 Avid Bioservices Inc Earnings Call Transcript
Dec 07, 2023

$5.29 (+1.73%)

Earnings
Avid Bioservices Inc Annual Shareholders Meeting Transcript
Oct 23, 2023
Q1 2024 Avid Bioservices Inc Earnings Call Transcript
Sep 07, 2023

$11.62 (-4.75%)

Earnings
Q4 2023 Avid Bioservices Inc Earnings Call Transcript
Jun 21, 2023

$15.57 (-2.87%)

Earnings
Q3 2023 Avid Bioservices Inc Earnings Call Transcript
Mar 13, 2023

$13.82 (-0.93%)

Earnings
Q2 2023 Avid Bioservices Inc Earnings Call Transcript
Dec 06, 2022

$14.88 (-3.31%)

Earnings
Avid Bioservices Inc at RBC Capital Markets Virtual Pharmaceutical CDMO Conference Transcript
Oct 03, 2022
Avid Bioservices Inc at Morgan Stanley Global Healthcare Conference Transcript
Sep 14, 2022
Q1 2023 Avid Bioservices Inc Earnings Call Transcript
Sep 06, 2022

$15.96 (-0.68%)

Earnings
Q4 2022 Avid Bioservices Inc Earnings Call Transcript
Jun 29, 2022

$15.17 (-2.38%)

Earnings
Avid Bioservices Inc at KeyBanc Capital Markets Life Sciences & MedTech Forum (Virtual) Transcript
Mar 23, 2022
Q3 2022 Avid Bioservices Inc Earnings Call Transcript
Mar 08, 2022

$17.53 (-3.42%)

Earnings
Q2 2022 Avid Bioservices Inc Earnings Call Transcript
Dec 07, 2021

$28.5 (+1.14%)

Earnings
Avid Bioservices Inc at Morgan Stanley Global Healthcare Conference (Virtual) Transcript
Sep 09, 2021
Q1 2022 Avid Bioservices Inc Earnings Call Transcript
Sep 08, 2021

$23.65 (+0.30%)

Earnings
Q4 2021 Avid Bioservices Inc Earnings Call Transcript
Jun 29, 2021

$24.07 (-1.67%)

Earnings
Q3 2021 Avid Bioservices Inc Earnings Call Transcript
Mar 08, 2021

$17.53 (-1.30%)

Earnings
Q2 2021 Avid Bioservices Inc Earnings Call Transcript
Dec 02, 2020

$9.5 (+8.20%)

Earnings
Avid Bioservices Inc Annual Shareholders Meeting Transcript
Oct 20, 2020
Avid Bioservices Inc at Morgan Stanley Global Healthcare Conference (Virtual) Transcript
Sep 17, 2020
Q1 2021 Avid Bioservices Inc Earnings Call Transcript
Sep 01, 2020

$8.52 (+1.55%)

Earnings
Q4 2020 Avid Bioservices Inc Earnings Call Transcript
Jun 30, 2020

$6.57 (+5.38%)

Earnings
Q3 2020 Avid Bioservices Inc Earnings Call Transcript
Mar 10, 2020

$5.99 (-0.83%)

Earnings
Q2 2020 Avid Bioservices Inc Earnings Call Transcript
Dec 09, 2019

$5.85 (+1.04%)

Earnings
Avid Bioservices Inc Annual Shareholders Meeting Transcript
Oct 09, 2019
Q1 2020 Avid Bioservices Inc Earnings Call Transcript
Sep 05, 2019

$7.05 (+4.44%)

Earnings
Q4 2019 Avid Bioservices Inc Earnings Call Transcript
Jun 27, 2019

$4 (+5.26%)

Earnings
Q3 2019 Avid Bioservices Inc Earnings Call Transcript
Mar 11, 2019

Earnings

Q3 2020 Avid Bioservices Inc Earnings Call Transcript

Mar 10, 2020 / 08:30PM GMT

Release Date Price: $5.99 (-0.83%)

Transcript 10-Q8-K

Operator

Good day, ladies and gentlemen, and welcome to the Avid Bioservices Third Quarter 2020 Financial Results Conference Call. (Operator Instructions) As a reminder, this conference may be recorded. I would now like to hand the conference over to Tim Brons of Avid's Investor Relations Group. Please go ahead.

Tim Brons

Vida Strategic Partners Inc. - EVP

Thank you. Good afternoon. And thank you for joining us. On today's call, we have Rick Hancock, Interim President and CEO; Dan Hart, Chief Financial Officer; and Timothy Compton, Chief Commercial Officer.

Today, we will be providing an overview of Avid Bioservices contract development and manufacturing business, including updates on corporate activities and financial results for the quarter ended January 31, 2020. After our prepared remarks, we will welcome your questions.

Before we begin, I'd like to caution that comments made during this conference call today, March 10, 2020, and will contain certain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of

Already have an account? Log in

Get the full story

Start 7-Day Free Trial

	Access to All Earning Calls and Stock Analysis
	30-Year Financial on one screen
	All-in-one Stock Screener with unlimited filters
	Customizable Stock Dashboard
	Real Time Insider Trading Transactions
	8,000+ Institutional investors’ 13F holdings
	Powerful Excel Add-in and Google sheets Add-on
	All data downloadable
	Quick customer support
	And much more...

30-Day 100% money back guarantee

You are not charged until the trial ends. Subscription fee may be tax deductible.

Excellent

4.6 out of 5

Trustpilot

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.